LINCOLN PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that the Hon''ble National Company Law Tribunal, Ahmedabad Bench, (''NCLT'') has sanctioned the scheme of Amalgamation of Lincoln Parenteral Limited ('Transferor Company') and Lincoln Pharmaceuticals Limited ('Transferee Company') and their respective shareholders and creditors vide its order dated September 14, 2021 and has been uploaded on the website of Hon''ble NCLT on September 15, 2021. <BR> <BR> The copy of order is attached as annexure to this letter.<BR> <BR> Appointed date of the Scheme is April 01, 2019. The Scheme will be effective upon filing of certified copy of the order of the Hon''ble NCLT with the Registrar of Companies, Gujarat.